Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1Lymphoid 1

Conditions

Leukemia 103Leukemia, Myeloid, Acute 93Myelodysplastic Syndromes 84Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma, Non-Hodgkin 58Multiple Myeloma 57Hodgkin Disease 52Leukemia, Lymphocytic, Chronic, B-Cell 49Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 42Lymphoma, Large B-Cell, Diffuse 40Neoplasms, Plasma Cell 39Lymphoma, Follicular 39Myeloproliferative Disorders 38Leukemia, Myelomonocytic, Chronic 37Leukemia, Myeloid, Accelerated Phase 37Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 33Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 33Blast Crisis 32Anemia, Refractory, with Excess of Blasts 31Primary Myelofibrosis 28Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Dendritic Cell Sarcoma, Interdigitating 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 20

Interventions

eltrombopag 8romiplostim 5Cytarabine 4Filgrastim 3Etoposide 3Daunorubicin 3Carboplatin 3oprelvekin 2fludarabine phosphate 2avatrombopag 2Thrombopoietin 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Doxorubicin 2Cyclosporine 2Busulfan 2sargramostim 1ofatumumab 1lusutrombopag 1leridistim 1bryostatin 1 1angiotensin I (1-7) 1alvocidib 1Vitamin E 1Vitamin B 12 1Vincristine 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Thrombocytopenia × Busulfan × Clear all
NCT00003619 2013-06-26

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00305708 2012-11-12

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

University of California, San Francisco

Phase 1/2 Completed
40 enrolled
Classical hematologyOther hematologic neoplasm

Congenital amegakaryocytic thrombocytopenia, Neutropenia, Severe Congenital, Autosomal Recessive 3, Fanconi Anemia, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Chronic-Phase, Anemia, Diamond-Blackfan

Data powered by HemOnc (CC BY 4.0) Colophon âš¡